×







We sell 100% Genuine & New Books only!

Biopatent Law Patent Strategies and Patent Management 2012 Edition at Meripustak

Biopatent Law Patent Strategies and Patent Management 2012 Edition by Andreas Hubel, Thilo Schmelcher, Ulrich Storz , Springer

Books from same Author: Andreas Hubel, Thilo Schmelcher, Ulrich Storz

Books from same Publisher: Springer

Related Category: Author List / Publisher List


  • Price: ₹ 10568.00/- [ 7.00% off ]

    Seller Price: ₹ 9828.00

Estimated Delivery Time : 4-5 Business Days

Sold By: Meripustak      Click for Bulk Order

Free Shipping (for orders above ₹ 499) *T&C apply.

In Stock

We deliver across all postal codes in India

Orders Outside India


Add To Cart


Outside India Order Estimated Delivery Time
7-10 Business Days


  • We Deliver Across 100+ Countries

  • MeriPustak’s Books are 100% New & Original
  • General Information  
    Author(s)Andreas Hubel, Thilo Schmelcher, Ulrich Storz
    PublisherSpringer
    ISBN9783642248450
    Pages44
    BindingPaperback
    LanguageEnglish
    Publish YearJanuary 2012

    Description

    Springer Biopatent Law Patent Strategies and Patent Management 2012 Edition by Andreas Hubel, Thilo Schmelcher, Ulrich Storz

    Patents protecting biotechnological invention are becoming ever more important. Because biotechnology has many differences with respect to other technologies, lessons learned in other fields of technology cannot simply be transferred to adopt a suitable strategy for dealing with biotechnology inventions. In this volume, general aspects of biopatent law will be discussed. This involves questions of patentability, including ethical issues and issues of technicality, as well as questions of patent exhaustion in cases were reproducible subject matter, like cells or seeds, is protected. Moreover, active and passive patent strategies are addressed. Further, insight will be given into patent lifetime management and additional protective measures, like supplementary protection certificates and data exclusivity. Here, strategies are discussed how market exclusivity can be extended as long as possible, which is particularly important for biopharmaceutical drugs, which create high R&D costs. Table of contents : - Andreas Huebel: General Issues of Biotech Patents.- Thilo Schmelcher: Active and Passive Patent Strategies.- Ulrich Storz: Patent Lifetime Management, SPCs and Data Exclusivity.



    Book Successfully Added To Your Cart